-
Fact Check: Is Marijuana Legalization Hurting Teen Mental Health?
Tuesday, May 14, 2024 - 11:42am | 2052This article was originally published on Leafly.com and appears here with permission. If you read this January 10 Wall Street Journal piece, you might conclude that a wave of cannabis-induced psychosis among teenagers is sweeping the country. The story highlights research on the...
-
Can Psychedelics Mushrooms Trigger Psychosis?
Saturday, March 25, 2023 - 3:20pm | 2064This article was originally published on Leafly and appears here with permission. Understanding the basic differences and similarities between tripping on shrooms and experiencing psychosis as a mental health condition. In the hours leading up to my first magic mushroom experience, I was...
-
Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says
Friday, February 17, 2023 - 5:51pm | 539The Department of Psychiatry at the University of Oxford will conduct an international study to investigate whether cannabis-based medicine can treat psychosis. The study has been awarded £16.5 million (US$19.8 million) by the charitable foundation Wellcome. It will involve 35 centers, mainly...
-
Psychosis-Related Outcomes Not Linked To State Cannabis Legalization, Finds Study Of 64M Americans
Monday, February 13, 2023 - 10:21pm | 411A recent study done by a team of Stanford University researchers concluded that there is no statistically significant difference in the rates of psychosis-related diagnoses and prescribed antipsychotics in states with medical or recreational cannabis policies as compared with...
-
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
Wednesday, June 8, 2022 - 9:17am | 1063Several recent studies have found a link between cannabis use and mental conditions such as psychosis and schizophrenia. A study published in the World Journal of Biological Psychiatry suggested that marijuana use increases the risk for a myriad of conditions ranging from transient psychotic states...
-
Acadia Stock Drops After FDA CRL For Pimavanserin Application In Hallucinations and Dementia-Related Psychosis
Monday, April 5, 2021 - 7:22am | 354The FDA has issued a Complete Response Letter (CRL) to Acadia Pharmaceuticals Inc (NASDAQ: ACAD) regarding its supplemental marketing application (for Nuplazid (pimavanserin) for the treatment of hallucinations and delusions associated with dementia-related psychosis (DRP...